Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Icrom Srl maintains 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This prosecution activity is limited to a distinct examiner and a distinct art unit. LEWOCZKO, EVAN MICHAEL is identified as the busiest examiner, managing the 1 pending action currently on file.
With only the pending office action, the company's current engagement with the patent office is consolidated. The outcome of this matter depends entirely on the review within the identified art unit and the specific examiner assigned.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LEWOCZKO, EVAN MICHAEL | 1 | — | — |
| Art Unit | Apps |
|---|---|
| 1612 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18546065 | SOLID COMPOSITION OF INDOCYANINE GREEN AND SODIUM FLUORESCEIN | LEWOCZKO, EVAN MICHAEL | 1612 | §103 | Final Rejection | 30d | Pending | Aug 10, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial